Dr. Bob Schenter was an early believer in the potential of Yttrium-90 (Y-90) and targeted isotope therapies to fight cancer with precision.

Working closely with scientists and researchers connected through Pacific Northwest National Laboratory (PNNL), he helped support the isotope side of therapies that could deliver radiation directly to tumors while minimizing damage to healthy tissue.

What fascinated Dr. Schenter was that Y-90 could be developed from nuclear waste products — transforming material once considered a problem into a potential life-saving medical treatment.

He believed this was the future of nuclear medicine:

Precision therapies using the power of isotopes to target cancer directly.

Radiogel and Y-90 represented exactly the kind of innovation he spent his life advocating for — practical, targeted, outpatient-based treatments designed to improve and save lives.

To Dr. Schenter, every isotope carried possibility.

And every breakthrough brought the world one step closer to defeating cancer.